ADAP Advocacy leverages patient advocates and other public health stakeholders to serve on numerous patient advisory committees:
RE: Drug Formularies
ADAP Advocacy works to improve access to timely, appropriate care and treatment for people living with HIV/AIDS being served by the State AIDS Drug Assistance Programs (ADAPs) under the Ryan White HIV/AIDS Program, including promoting robust drug formularies to best serve the needs of clients. Whenever feasible, ADAP Advocacy strongly supports "open" drug formularies.
Learn more about the ADAP State Drug Formulary Patient Advisory Committee.
Apply for membership: ADAP State Drug Formulary Patient Advisory Committee Membership
RE: Long-Acting Injectables
ADAP Advocacy strives to identify best practices on how to improve patient access to long-acting injectable therapies for the treatment of (and prevention of) HIV/AIDS. As general guidelines, they would be designed to help State AIDS Drug Assistance Programs (ADAPs), and other relevant payers, remove the barriers to accessing injectable HIV-related therapies, as well as other non-ARV, health-related injectable therapies.
Learn more about the ADAP Long-Acting Injectables Patient Advisory Committee.
Apply for membership: ADAP Long-Acting Injectables Patient Advisory Committee Membership
RE: 340B Drug Pricing Program
ADAP Advocacy ensures the voice of people living with HIV/AIDS shall always be at the table and the center of the discussion, including on how supports and services are financed under the Ryan White HIV/AIDS Program. To that end, reforming the 340B Drug Pricing Program is of paramount concern by returning the program to its original legislative intent: putting the patient first.
Learn more about the Ryan White Grantee 340B Patient Advisory Committee.
Apply for membership: Ryan White Grantee 340B Patient Advisory Committee Membership - (currently closed)